Lung Carcinoid Tumor: Clinical Trials

7 trials for Lung Carcinoid Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated, 1 unknown, 1 withdrawn. 3 Not applicable, 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Terminated 1, Unknown 1, Withdrawn 1
Phase 12Completed 2
Phase 22Completed 2

Follow Lung Carcinoid Tumor: new trials by email Literature Review of Lung Carcinoid Tumor trials Research Report on Lung Carcinoid Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers
E-mail, Exercise Intervention, Quality-of-Life Assessment - Caregiver, Lobectomy Patient
Not applicableWithdrawnCity of Hope Medical Center2021-05-152021-08-12
Bronchoscopic Laser Ablation of Peripheral Lung Tumors
Cone-Beam Computed Tomography, Conventional Surgery, Laser Ablation - Lung Carcinoid Tumor, Lung Non-Small Cell Carcinoma
Not applicableTerminatedM.D. Anderson Cancer Center42018-09-182023-02-16
Active Surveillance in Early Lung Cancer
Active Surveillance - Stage IA Non-small Cell Lung Cancer, Lung Carcinoid Tumor
Not applicableUnknownUniversity of Vermont Medical Center262018-07-312020-07-16
Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Laboratory Biomarker Analysis, Pharmacological Study, Temsirolimus - Adult Solid Neoplasm, Lung Carcinoid Tumor
Phase 1CompletedNational Cancer Institute (NCI)212012-03-012015-10-06
Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
Cixutumumab, Everolimus, Laboratory Biomarker Analysis - Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor
Phase 1CompletedNational Cancer Institute (NCI)272010-10-012016-07-15
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
Bevacizumab, Temsirolimus - Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma
Phase 2CompletedNational Cancer Institute (NCI)2522009-09-082019-01-25
Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer
Laboratory Biomarker Analysis, Pazopanib Hydrochloride, Pharmacological Study - Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor
Phase 2CompletedNational Cancer Institute (NCI)522007-03-012020-04-03

Narrower conditions

Carcinoma, Non-Small-Cell Lung (3)  ·  Somatostatinoma (3)  ·  Glucagonoma (2)  ·  Insulinoma (2)  ·  Lung Neoplasms (2)  ·  Zollinger-Ellison Syndrome (2)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Medullary (1)  ·  Carcinoma, Merkel Cell (1)  ·  Carcinoma, Renal Cell (1)  ·  Fallopian Tube Neoplasms (1)  ·  Motor Activity (1)  ·  Multiple Endocrine Neoplasia Type 1 (1)  ·  Ovarian Neoplasms (1)  ·  Paraganglioma (1)

Broader conditions

Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Adenocarcinoma (4)  ·  Carcinoma (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Bronchial Neoplasms (3)  ·  Carcinoma, Bronchogenic (3)  ·  Carcinoma, Islet Cell (3)  ·  Carcinoma, Neuroendocrine (3)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Lung Diseases (3)

Interventions

Sirolimus (2)  ·  temsirolimus (2)  ·  Acetates (1)  ·  Bevacizumab (1)  ·  Communication Devices for People with Disabilities (1)  ·  Disulfides (1)  ·  Everolimus (1)  ·  Immunoglobulin G (1)  ·  Laser Therapy (1)  ·  Octreotide (1)  ·  Salts (1)  ·  Watchful Waiting (1)  ·  cixutumumab (1)  ·  pazopanib (1)  ·  trebananib (1)

Sponsors

National Cancer Institute (NCI) (4)  ·  City of Hope Medical Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  University of Vermont Medical Center (1)

Countries

United States (5)  ·  Canada (2)

Top investigators

James Yao (2)  ·  Henry Pitot (1)  ·  Philippe Bedard (1)  ·  Roberto F Casal (1)  ·  Virginia Sun (1)

Results publications

PMID 25318437, PMID 25488966, PMID 25900182, PMID 25956795, PMID 37702588

NIH funding

P30CA016672 (2), N01CM00032 (1), N01CM00038 (1), N01CM00039 (1), N01CM00070 (1), N01CM00071 (1), N01CM00099 (1), N01CM00100 (1), N01CM62201 (1), N01CM62202 (1), N01CM62203 (1), N01CM62204 (1), N01CM62205 (1), N01CM62206 (1), N01CM62207 (1)